Trident Lifeline partners with NIPER-A to develop Vorinostat, a drug for rare cancers

From Google: 2025-03-06 00:58:00

Trident Lifeline has partnered with NIPER-A to develop Vorinostat, a drug for rare cancers. The partnership aims to improve access to this life-saving medication. Vorinostat is currently in high demand due to its effectiveness in treating certain types of cancer. This collaboration is expected to boost production and distribution of the drug, benefiting patients in need. Trident Lifeline’s alliance with NIPER-A marks a significant step towards providing better healthcare solutions for individuals battling rare forms of cancer.



Read more at Google: Trident Lifeline jumps on collaboration with NIPER-A for Vorinostat, a rare cancer drug – Business Standard